Johnson & Johnson (JNJ) Market Capitalization (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Market Capitalization came in at $613.7 billion in Q2 2026, up 67.2% year-over-year from $367.1 billion in Q2 2025, and up 6.03% quarter-over-quarter from $578.8 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Market Capitalization (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Market Capitalization across 18 years of filings, most recently posting $613.7 billion for Q2 2026.
- In Q2 2026, Market Capitalization rose 67.2% year-over-year to $613.7 billion; the TTM figure through Jun 2026 stood at $613.7 billion (up 67.2% YoY), while the FY2025 annual figure was $500.4 billion, up 43.28% from the prior year.
- Market Capitalization came in at $613.7 billion for Q2 2026 at Johnson & Johnson, up from $578.8 billion in the prior quarter.
- In the past five years, Market Capitalization ranged from a high of $613.7 billion in Q2 2026 to a low of $349.2 billion in Q4 2024.
- Average Market Capitalization over 5 years is $432.7 billion, with a median of $427.1 billion recorded in 2022.
- Year-over-year, Market Capitalization declined 18.21% in 2024 and soared 67.2% in 2026.
- Over 5 years, Market Capitalization stood at $427.1 billion in 2022, then decreased by 11.6% to $377.6 billion in 2023, then slipped by 7.5% to $349.2 billion in 2024, then surged by 43.28% to $500.4 billion in 2025, then rose by 22.65% to $613.7 billion in 2026.
- Per Business Quant data, the three most recent Market Capitalization figures were $613.7 billion in Q2 2026, $578.8 billion in Q1 2026, and $500.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 613.70 Bn |
| Mar 29, 2026 | 578.82 Bn |
| Dec 28, 2025 | 500.37 Bn |
| Sep 28, 2025 | 432.97 Bn |
| Jun 29, 2025 | 367.05 Bn |
| Mar 30, 2025 | 393.90 Bn |
| Dec 29, 2024 | 349.22 Bn |
| Sep 29, 2024 | 388.59 Bn |
| Jun 30, 2024 | 351.84 Bn |
| Mar 31, 2024 | 380.71 Bn |
| Dec 31, 2023 | 377.55 Bn |
| Oct 1, 2023 | 374.93 Bn |
| Jul 2, 2023 | 430.18 Bn |
| Apr 2, 2023 | 402.80 Bn |
| Jan 1, 2023 | 460.05 Bn |
| Oct 2, 2022 | 427.10 Bn |
| Jul 3, 2022 | 471.99 Bn |
| Apr 3, 2022 | 468.89 Bn |
| Jan 2, 2022 | 449.79 Bn |
| Oct 3, 2021 | 422.45 Bn |